Next Article in Journal
Management of Bleeding from Unresectable Gastric Cancer
Previous Article in Journal
Differential Roles of Dendritic Cells in Expanding CD4 T Cells in Sepsis
Open AccessReview

A Brief Overview of the Antitumoral Actions of Leelamine

1
Faculty of Pharmacy, University of Paris Descartes, 75006 Paris, France
2
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore
3
College of Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea
*
Authors to whom correspondence should be addressed.
Biomedicines 2019, 7(3), 53; https://doi.org/10.3390/biomedicines7030053
Received: 18 June 2019 / Revised: 9 July 2019 / Accepted: 15 July 2019 / Published: 19 July 2019
(This article belongs to the Section Natural Compounds in Biomedicine)
  |  
PDF [789 KB, uploaded 19 July 2019]
  |  

Abstract

For the last couple of decades, natural products, either applied singly or in conjunction with other cancer therapies including chemotherapy and radiotherapy, have allowed us to combat different types of human cancers through the inhibition of their initiation and progression. The principal sources of these useful compounds are isolated from plants that were described in traditional medicines for their curative potential. Leelamine, derived from the bark of pine trees, was previously reported as having a weak agonistic effect on cannabinoid receptors and limited inhibitory effects on pyruvate dehydrogenase kinases (PDKs). It has been reported to possess a strong lysosomotropic property; this feature enables its assembly inside the acidic compartments within a cell, such as lysosomes, which may eventually hinder endocytosis. In this review, we briefly highlight the varied antineoplastic actions of leelamine that have found implications in pharmacological research, and the numerous intracellular targets affected by this agent that can effectively negate the oncogenic process. View Full-Text
Keywords: leelamine; malignancies; molecular mechanisms, preclinical models leelamine; malignancies; molecular mechanisms, preclinical models
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Merarchi, M.; Jung, Y.Y.; Fan, L.; Sethi, G.; Ahn, K.S. A Brief Overview of the Antitumoral Actions of Leelamine. Biomedicines 2019, 7, 53.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top